HealthTree Podcast for Multiple Myeloma
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Latest episodes
Nov 20, 2015 • 1h 20min
Myeloma Crowd Radio: Dr. Ola Landgren, MD, PhD, Memorial Sloan Kettering
New developments for multiple myeloma are happening at an ever increasing pace. Dr. Ola Landgren is Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and heavily involved in the direction of myeloma research, both nationally and internationally. In this show he will give a wrap up of the recent Rome International Myeloma Working Group meeting as well as an ASH preview (for the upcoming December conference). He will also share up and coming clinical trials at Memorial Sloan Kettering Cancer Center to incorporate these new treatments into clinical practice. Learn what new drugs will be available and how they can be used in the myeloma clinic.
Nov 9, 2015 • 1h 6min
Myeloma Crowd Radio: Dr. Tomer Mark, MD, MSc, Weill Cornell Medical Center
Treatment for multiple myeloma is all about the combinations. Recently we've been hearing about the "BIRD" combinations. What are they and how effective are they? Learn from Dr. Tomer Mark, MD, MSc from Weill Cornell Medical Center about this new combination and what it means for myeloma patients.
Oct 16, 2015 • 1h 3min
Myeloma Crowd Radio: Dr. Djordje Atanackovic, MD, Huntsman Cancer Institute
With the explosion in immunotherapies for multiple myeloma, we have heard there are "windows" of best and most effective use. What are those windows and when is the best time to use these new approaches? The field is ever growing and Dr. Djordje Atanackovic will share how and when to use these new tools for a myeloma patient's best care.
Thanks to our episode sponsor, Takeda Oncology
Oct 8, 2015 • 59min
Myeloma Crowd Radio: Dr. Adam Cohen, MD, Perelman Center for Advanced Medicine
The University of Pennsylvania had tremendous results with a recent clinical trial using a CAR T cell treatment targeting CD19 for a myeloma patient. The results were so impressive that some wonder if they have been able to eliminate the myeloma stem cell clone for one patient who had relapsed 9 therapies and had a high-risk genetic feature. Learn more about this success and where UPENN is going next using CAR therapy with Dr. Adam Cohen, MD, Director of Myeloma Immunotherapy at the Perelman Center for Advanced Medicine at UPENN.
Thanks to our episode sponsor, Amgen.
Sep 25, 2015 • 1h 16min
Myeloma Crowd Radio: Dr. Daniel Fowler, MD, NIH
Immunotherapies are making their way into the clinic and as they do, more exciting options will be available for patients. Researchers are now studying the best possible way to leverage the standard and effective multiple myeloma treatments with ways to empower the immune system to fight myeloma. Learn what Dr. Daniel Fowler, MD of the NIH is doing to use a Th1 and Th2 immune therapy treatment in combination with stem cell transplant in an early clinical trial.
Special thanks to our Myeloma Crowd Radio episode sponsor, Amgen.
Sep 18, 2015 • 1h 20min
Myeloma Crowd Radio: Dr. Don Benson, MD, PhD, Ohio State University
Dr. Don Benson, MD, PhD of The James Cancer Center at Ohio State University is a multiple myeloma specialist with deep expertise in immunotherapy. He shares the growing and exciting world of immunotherapies in multiple myeloma - how they work and how they are opening up an exciting new set of opportunities for myeloma patients.
Aug 17, 2015 • 1h 15min
Myeloma Crowd Radio: Dr. Mike Thompson, MD, PhD, Aurora Health Care
Social media tools can be used by doctors and patients to speed the time to cure, especially for rare diseases like multiple myeloma. Learn from myeloma specialist and oncologist Dr. Mike Thompson, MD, PhD from the Aurora Health Care how he is driving social media adoption in oncology to increase the speed for the discovery of a cure and what that means in the every day lives of myeloma patients.
Special Thanks to today's episode sponsor, Takeda Oncology.
Jul 29, 2015 • 1h 23min
Myeloma Crowd Radio: Dr. Jens Hillengass, MD, University of Heidelberg
Could an MRI predict how a multiple myeloma patient's disease will progress and respond to treatment? Learn what Dr. Jens Hillengass, MD of the University of Heidelberg is doing to use the latest in imaging techniques to learn more about an individual patient's myeloma and what it means for their outcomes and care.
Jul 21, 2015 • 1h 10min
Myeloma Crowd Radio: Dr. Alfred Garfall, MD, University of Pennsylvania
The University of Pennsylvania has led the charge in the US for CAR T cells for blood cancers with impressive results in leukemia. Dr. Alfred Garfall, MD was recently covered in Targeted Oncology for his research using CD19 in multiple myeloma. Learn more about the lessons learned in leukemia and how the exciting field is expanding and maturing in multiple myeloma.
Jun 12, 2015 • 1h 4min
Myeloma Crowd Radio: Dr. Brian Van Ness, PhD, University of Minnesota, PhD
Could multiple myeloma genetics give us clues into who will respond to standard treatments and who will not? Dr. Brian Van Ness, PhD of the University of Minnestota shares his study to do just that. In a collaboration between the Unversity of Minnesota and the Mayo Clinic, Dr. Van Ness will describe his study to determine who will respond to treatment (or not) even before the treatment is given. Learn more about how standard therapies can be effectively used in this important show.
